Legislators
Bills
Statements
Lobbying
Travel
Searching...- Lobbying
- Lobbying by Takeda Pharmaceuticals U.S.A., Inc.
Lobbying Relationship
Bills mentioned
S.1509: Treat and Reduce Obesity Act of 2015
Sponsor: Thomas R. Carper (D-Del.)
H.R.2404: Treat and Reduce Obesity Act of 2015
Sponsor: Erik Paulsen (R-Minn.)
H.R.2415: Treat and Reduce Obesity Act of 2013
Sponsor: Bill Cassidy (R-La.)
S.1184: Treat and Reduce Obesity Act of 2013
Sponsor: Thomas R. Carper (D-Del.)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
| Lobbyist | Covered positions? |
|---|---|
| Billy Wynne | Health Policy Counsel, Senate Finance Committee |
| Katie Pahner | Health Insurance Specialist, Ctrs. for Medicare/Medicaid Svc |
| Gary Palmquist | LegDir-Dennis Cardoza,Bob Clement,Ken Bentsen |
| Catherine Finley | StaffDirAging;HlthPolAdvSmithSnowe;LCDeWine |
| Jessie Brairton | SrLA/LA:CongL.Smith;LC,Asst:SenAgingComm |
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate